Australia’s medical regulator, the Therapeutic Goods Administration, TGA, said on Thursday that it has provisionally approved the Moderna COVID-19 vaccine for use in individuals aged six years and older.
According to the report, the decision follows the provisional approvals granted by the TGA to Moderna for the use of the vaccine, SPIKEVAX, in individuals aged 12 years and older in September 2021.
The TGA said in a statement, “As for other age groups, the use of this vaccine in children aged six to 11 years should be administered as two doses at least 28 days apart.
It said a lower dose of 0.25 mL 50 micrograms will be given to children six to 11 years, compared to the 0.5 ml, 100 micrograms, dose used for those 12 years and older.
SPIKEVAX has now been added to Pfizer’s coronavirus vaccine as the recommended vaccine for Australian children.
BBC/Taiwo Akinola
pub-5160901092443552
Related Posts
